Stay updated on ARO-APOC3 in Mixed Dyslipidemia Clinical Trial
Sign up to get notified when there's something new on the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page.

Latest updates to the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check19 days agoChange DetectedResults were posted on 2026-02-24 and the study record was updated to reflect the new title 'Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia (MUIR)' with expanded design details and endpoints.SummaryDifference5%

- Check33 days agoChange DetectedResults status changed from 'No Results Posted' to 'Results Submitted', indicating that study results have been submitted. The page revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded a 'Show glossary' option and labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with revision 3.4.0; removed the older labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' with revision 3.3.4.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

Stay in the know with updates to ARO-APOC3 in Mixed Dyslipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page.